VSTM2A Antikörper (Middle Region)
Kurzübersicht für VSTM2A Antikörper (Middle Region) (ABIN633890)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Spezifität
- VSTM2 A antibody was raised against the middle region of VSTM2
-
Aufreinigung
- Affinity purified
-
Immunogen
- VSTM2 A antibody was raised using the middle region of VSTM2 corresponding to a region with amino acids DISHKLQISKVRKKDEGLYECRVTDANYGELQEHKAQAYLKVNANSHARR
-
-
-
-
Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
VSTM2A Blocking Peptide, (ABIN937392), is also available for use as a blocking control in assays to test for specificity of this VSTM2A antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of VSTM0 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- VSTM2A (V-Set and Transmembrane Domain Containing 2A (VSTM2A))
-
Andere Bezeichnung
- VSTM2A
-
Hintergrund
- This pseudogene is a member of the cytochrome P450 geneuperfamily. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. It is possible that, in rare cases, a combination of two SNPs in this gene may result in an open reading frame encoding a functional enzyme which metabolizes codeine to morphine.
-
Molekulargewicht
- 26 kDa (MW of target protein)
Target
-